New research approaches in spinal muscular atrophy (SMA) are now targeting muscle. In this episode, host Diana Castro, MD, discusses myostatin—a new potential target in SMA. She is joined by Jena Krueger, MD, a pediatric neurologist, and Leslie Cortes, PhD, and Adam Fogel, PhD, researchers from Scholar Rock, to talk about what myostatin is, why it matters in muscle, and why it’s such an important focus for future developments in SMA.
New research approaches in spinal muscular atrophy (SMA) are now targeting muscle. In this episode, host Diana Castro, MD, discusses myostatin—a new potential target in SMA. She is joined by Jena Krueger, MD, a pediatric neurologist, and Leslie Cortes, PhD, and Adam Fogel, PhD, researchers from Scholar Rock, to talk about what myostatin is, why it matters in muscle, and why it’s such an important focus for future developments in SMA.